PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1576990
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1576990
Pelvic Floor Electric Stimulator Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
The Global Pelvic Floor Electric Stimulator Market was valued at USD 244.1 million, with an estimated 11.4% CAGR from 2024 to 2032. A significant driver for this market is the rapidly aging global population. The WHO highlights that by 2030, one in every six individuals worldwide will be aged 60 years or older. This demographic transition, with the elderly population projected to swell from 1 billion in 2020 to 1.4 billion, is amplifying the prevalence of pelvic floor disorders. As individuals age, they face weakened muscles and reduced tissue elasticity, heightening the risk of urinary incontinence. Consequently, there is an escalating demand for therapeutic solutions tailored for the elderly.
The pelvic floor electric stimulator industry is segmented based on product type, application, end use , and region.
When examining product types, the market distinguishes between mobile and fixed stimulators. Projections suggest that the mobile segment will soar to USD 415.9 million by 2032. The allure of mobile stimulators lies in their convenience and portability, allowing users to seamlessly integrate pelvic floor exercises into their daily routines. This innovative home healthcare solution enhances accessibility, particularly for those in remote locales. Moreover, features like smartphone connectivity and personalized tracking not only captivate users but also promote consistent engagement. Given the rising smartphone adoption and a tilt towards non-invasive treatments, the segment's growth trajectory appears steep.
Applications of pelvic floor electric stimulators span urinary incontinence, neurodegenerative diseases, and sexual dysfunction. In 2023, the urinary incontinence segment dominated with a valuation of USD 194.8 million. The surging prevalence of urinary incontinence, notably among the elderly, has spurred demand for effective non-invasive treatments. The inclination of patients towards conservative therapies, coupled with healthcare professionals' endorsement of pelvic floor electric stimulators, has further fueled their uptake. The market growth is also buoyed by heightened awareness, better diagnosis rates, and technological innovations.
In the U.S., the pelvic floor electric stimulator market is on track to hit USD 245.9 million by 2032. The U.S. is witnessing a pronounced uptick in its aging demographic, a group more susceptible to pelvic floor disorders. Data from the Urban Institute underscores this trend as the population aged 65 and above is set to more than double in the next four decades, reaching a staggering 80 million by 2040. As this demographic expands, so does the prevalence of conditions like urinary incontinence and pelvic pain, driving the demand for solutions like pelvic floor electric stimulators.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increase in the prevalence of urinary incontinence
- 3.2.1.2 Increasing awareness initiatives
- 3.2.1.3 Rise in geriatric population base
- 3.2.1.4 Growing demand for non-invasive treatment option
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Limited accessibility and distribution
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Mobile
- 5.3 Fixed
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Urinary incontinence
- 6.3 Neurodegenerative diseases
- 6.4 Sexual dysfunction
Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Clinics
- 7.4 Home care settings
- 7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Athena Feminine Technologies, Inc.
- 9.2 Axena Health, Inc.
- 9.3 Beacmed s.r.l.
- 9.4 Chiaro Technology Limited
- 9.5 Everyway Medical Instruments Co., Ltd.
- 9.6 InControl Medical.
- 9.7 Laborie
- 9.8 Medtronic plc
- 9.9 Nidd Valley Medical
- 9.10 PeriCoach
- 9.11 Shenzhen XFT Medical Limited
- 9.12 TensCare Ltd
- 9.13 The Prometheus Group
- 9.14 Verity Medical Ltd
- 9.15 Zynex, Inc.
